Trial Profile
Phase I Study of Intravenous Triapine (IND 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs OCX 191 (Primary) ; Cisplatin
- Indications Cervical cancer; Endometrial cancer; Ovarian cancer; Vulvovaginal cancer
- Focus Adverse reactions
- 16 Mar 2010 Actual patient number (11) added as reported by ClinicalTrials.gov.
- 16 Mar 2010 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
- 01 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.